Pfizer Inc. incurs research and development expenses for its pharmaceutical products. The cost accountant observed that research and development expenses vary based on the scope and complexity of clinical trials, regulatory requirements, and technological advancements. Additionally, research and development expenses tend to increase during product development stages and clinical testing phases. Discuss the cost behavior of research and development expenses for Pfizer Inc., considering both variable and fixed components, and provide recommendations for cost management.